Idiopathic Thrombocytopenic Purpura
📧 Sign up to get email alerts when something new happens for Idiopathic Thrombocytopenic Purpura.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-08-30Clinical Trial Update: Alemtuzumab and Rituximab in the Treatment of Refractory Autoimmune Cytopenias [Phase 2, Phase 3]
This clinical trial investigates combining alemtuzumab and rituximab to treat refractory autoimmune cytopenias, including idiopathic thrombo…
-
CLINICAL_TRIALS trial_result · 2010-07-16Clinical Trial Update: Effects of Long-term Dosing of AMG 531 on Bone Marrow Morphology
A completed trial evaluating the effects of long-term AMG 531 (romiplostim) dosing on bone marrow morphology in patients with idiopathic thr…
-
CLINICAL_TRIALS trial_result · 2010-05-12Clinical Trial Update: Retrospective & Prospective Observational Study of Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Amgen sponsored a retrospective and prospective observational study of patients with idiopathic thrombocytopenic purpura (ITP); the trial st…
-
CLINICAL_TRIALS trial_result · 2009-02-03Clinical Trial Update: Treatment of Idiopathic Thrombocytopenic Purpura (ITP) With Subcutaneously Administered Anti-D [Phase 2]
A Phase 2 trial evaluating subcutaneously administered Anti-D for idiopathic thrombocytopenic purpura has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers
A completed NHLBI observational trial in immune thrombocytopenia examined how platelet counts relate to endogenous thrombopoietin levels, en…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.